JPWO2023219152A5 - - Google Patents
Info
- Publication number
- JPWO2023219152A5 JPWO2023219152A5 JP2024520494A JP2024520494A JPWO2023219152A5 JP WO2023219152 A5 JPWO2023219152 A5 JP WO2023219152A5 JP 2024520494 A JP2024520494 A JP 2024520494A JP 2024520494 A JP2024520494 A JP 2024520494A JP WO2023219152 A5 JPWO2023219152 A5 JP WO2023219152A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- purified
- product
- amino acid
- lithium salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022079708 | 2022-05-13 | ||
| JP2022079712 | 2022-05-13 | ||
| EP22216504.5A EP4206322A3 (en) | 2021-12-28 | 2022-12-23 | Polypeptide and method for producing amino acid using same |
| TW111149813A TW202342741A (zh) | 2021-12-28 | 2022-12-23 | 多胜肽及使用其之胺基酸的製造方法 |
| PCT/JP2022/047741 WO2023127752A1 (ja) | 2021-12-28 | 2022-12-23 | ポリペプチド及びこれを用いたアミノ酸の製造方法 |
| PCT/JP2023/017844 WO2023219152A1 (ja) | 2022-05-13 | 2023-05-12 | リチウム塩の析出工程を含む、アミノ酸の塩若しくはペプチド化合物の塩又はこれらの溶媒和物の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023219152A1 JPWO2023219152A1 (cg-RX-API-DMAC10.html) | 2023-11-16 |
| JPWO2023219152A5 true JPWO2023219152A5 (cg-RX-API-DMAC10.html) | 2026-05-20 |
Family
ID=88730292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520494A Pending JPWO2023219152A1 (cg-RX-API-DMAC10.html) | 2022-05-13 | 2023-05-12 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250368680A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4520748A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JPWO2023219152A1 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20250012580A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023219152A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021090856A1 (ja) | 2019-11-07 | 2021-05-14 | 中外製薬株式会社 | 立体障害の大きなアミノ酸を含むペプチド化合物の製造方法 |
| AR125800A1 (es) | 2021-05-07 | 2023-08-16 | Chugai Pharmaceutical Co Ltd | Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n |
| CN121532404A (zh) | 2023-09-28 | 2026-02-13 | 中外制药株式会社 | 用于使用混合酸酐程序生产肽化合物的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6046117B2 (ja) * | 1974-11-15 | 1985-10-14 | 明治製菓株式会社 | セフアロスポリン誘導体の製造方法 |
| US5055594A (en) * | 1990-07-19 | 1991-10-08 | Becton, Dickinson And Company | Fluorogenic trypotophanase substrates |
| DE4119544C1 (cg-RX-API-DMAC10.html) * | 1991-06-13 | 1992-10-15 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig, De | |
| KR20010033648A (ko) | 1997-12-27 | 2001-04-25 | 후루타 타케시 | β-할로게노-α-아미노카르복실산 및 페닐시스테인유도체와, 그의 중간체의 제조 방법 |
| EP1179530A4 (en) | 2000-02-17 | 2005-07-27 | Kaneka Corp | METHODS FOR PREPARING AMINOACID DERIVATIVES WITH OPTICAL ACTIVITY |
| EP1358163A1 (en) * | 2001-01-23 | 2003-11-05 | Eli Lilly And Company | Melanocortin receptor agonists |
| CN101456859B (zh) * | 2009-01-06 | 2011-07-20 | 华南理工大学 | 抗病毒药物缬昔洛韦的制备方法 |
| CN105273023B (zh) * | 2014-06-26 | 2018-11-06 | 昆明积大制药股份有限公司 | 一种阿糖胞苷5’-o-l-缬氨酸酯盐酸盐的制备方法 |
| CN105272910A (zh) * | 2015-10-28 | 2016-01-27 | 成都欣捷高新技术开发有限公司 | 一种制备硫酸艾沙康唑关键中间体的方法 |
| GB201805174D0 (en) * | 2018-03-29 | 2018-05-16 | Univ Leeds Innovations Ltd | Compounds |
-
2023
- 2023-05-12 WO PCT/JP2023/017844 patent/WO2023219152A1/ja not_active Ceased
- 2023-05-12 KR KR1020247040256A patent/KR20250012580A/ko active Pending
- 2023-05-12 US US18/864,049 patent/US20250368680A1/en active Pending
- 2023-05-12 EP EP23803626.3A patent/EP4520748A4/en active Pending
- 2023-05-12 JP JP2024520494A patent/JPWO2023219152A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4597237B2 (ja) | 置換シクロペンタン誘導体の調製方法及びその新規結晶構造 | |
| US9676803B2 (en) | Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine | |
| CN106459150B (zh) | 合成五肽的制造方法 | |
| CA2303528A1 (en) | New npy antagonists | |
| RU2280641C2 (ru) | Способ получения производных фенилаланина и их полупродуктов | |
| CN103443084A (zh) | 制备苯达莫司汀的方法 | |
| US20240262805A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| DE3939747A1 (de) | Renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| CA2106673A1 (en) | Improved process for the preparation of [1s-(1r*,2s*,3r*)]-n-(4-morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide | |
| US12522611B2 (en) | Process for the preparation of high pure Eribulin and its Mesylate salt | |
| SI21800A (sl) | Nov postopek sinteze perindoprila | |
| US3445447A (en) | Tert-amyloxycarbonyl derivatives of amino acids | |
| JPS6148495B2 (cg-RX-API-DMAC10.html) | ||
| JP4852282B2 (ja) | Ｎ−カルボン酸無水物の製造方法 | |
| CN1839123A (zh) | 获得氨酯保护的α－氨基酸N－羧酸酐的方法 | |
| RU2741389C1 (ru) | Способ получения промежуточного соединения для синтеза лекарственного средства | |
| KR840000962B1 (ko) | 카복실산아마이드의 제조방법 | |
| CN87107492A (zh) | 2-(1-戊基-3-胍基)-4-(2-甲基-4-咪唑基)噻唑及其二盐酸盐三水合物结晶的制备方法 | |
| JP3168563B2 (ja) | ホスネートｎｍｄａ拮抗剤の調製用ｎ−トリチルアスパラギン酸誘導体類 | |
| JPS5849547B2 (ja) | ピラゾリンユウドウタイノ セイゾウホウ | |
| JPH07502538A (ja) | ３（ｓ）−メチルヘプタン酸の製造方法およびその中間体 | |
| JPS6132304B2 (cg-RX-API-DMAC10.html) | ||
| JPH0714906B2 (ja) | 保護アミノ酸の生成方法 | |
| JPH029859A (ja) | スルホニウム化合物の製造方法 | |
| JPH04244088A (ja) | セファロスポリン誘導体 |